Topoisomerase inhibitor-induced apoptosis accompanied by down-regulation of Bcl-2 in human lung cancer cells. [electronic resource]
- Anticancer research
- 4029-37 p. digital
Publication Type: Journal Article
0250-7005
Antineoplastic Agents, Phytogenic--pharmacology Apoptosis--drug effects Camptothecin--analogs & derivatives Carcinoma, Non-Small-Cell Lung--drug therapy Carcinoma, Small Cell--drug therapy Down-Regulation--drug effects Enzyme Inhibitors--pharmacology Etoposide--pharmacology Flow Cytometry Humans Irinotecan Lung Neoplasms--drug therapy Proto-Oncogene Proteins--biosynthesis Proto-Oncogene Proteins c-bcl-2--biosynthesis Topoisomerase I Inhibitors Topoisomerase II Inhibitors Tumor Cells, Cultured Tumor Suppressor Protein p53--biosynthesis bcl-2-Associated X Protein